324 related articles for article (PubMed ID: 18302934)
1. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain.
Pinheiro MP; Iulek J; Cristina Nonato M
Biochem Biophys Res Commun; 2008 May; 369(3):812-7. PubMed ID: 18302934
[TBL] [Abstract][Full Text] [Related]
2. Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction.
Inaoka DK; Sakamoto K; Shimizu H; Shiba T; Kurisu G; Nara T; Aoki T; Kita K; Harada S
Biochemistry; 2008 Oct; 47(41):10881-91. PubMed ID: 18808149
[TBL] [Abstract][Full Text] [Related]
3. Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.
Cheleski J; Rocha JR; Pinheiro MP; Wiggers HJ; da Silva AB; Nonato MC; Montanari CA
Eur J Med Chem; 2010 Dec; 45(12):5899-909. PubMed ID: 20965617
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenase.
Inaoka DK; Iida M; Hashimoto S; Tabuchi T; Kuranaga T; Balogun EO; Honma T; Tanaka A; Harada S; Nara T; Kita K; Inoue M
Bioorg Med Chem; 2017 Feb; 25(4):1465-1470. PubMed ID: 28118956
[TBL] [Abstract][Full Text] [Related]
5. Genetic diversity and kinetic properties of Trypanosoma cruzi dihydroorotate dehydrogenase isoforms.
Sariego I; Annoura T; Nara T; Hashimoto M; Tsubouchi A; Iizumi K; Makiuchi T; Murata E; Kita K; Aoki T
Parasitol Int; 2006 Mar; 55(1):11-6. PubMed ID: 16172019
[TBL] [Abstract][Full Text] [Related]
6. Computational study of the mechanism of half-reactions in class 1A dihydroorotate dehydrogenase from Trypanosoma cruzi.
Silva Nde F; Lameira J; Alves CN; Martí S
Phys Chem Chem Phys; 2013 Nov; 15(43):18863-71. PubMed ID: 24084894
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of dihydroorotate dehydrogenase from Leishmania major.
Cordeiro AT; Feliciano PR; Pinheiro MP; Nonato MC
Biochimie; 2012 Aug; 94(8):1739-48. PubMed ID: 22542640
[TBL] [Abstract][Full Text] [Related]
8. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L
Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515
[TBL] [Abstract][Full Text] [Related]
9. Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Hurt DE; Sutton AE; Clardy J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1610-5. PubMed ID: 16406782
[TBL] [Abstract][Full Text] [Related]
10. Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor.
Hurt DE; Widom J; Clardy J
Acta Crystallogr D Biol Crystallogr; 2006 Mar; 62(Pt 3):312-23. PubMed ID: 16510978
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function.
Rowland P; Björnberg O; Nielsen FS; Jensen KF; Larsen S
Protein Sci; 1998 Jun; 7(6):1269-79. PubMed ID: 9655329
[TBL] [Abstract][Full Text] [Related]
12. Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
Hegewald J; Gross U; Bohne W
Mol Biochem Parasitol; 2013 Jul; 190(1):6-15. PubMed ID: 23747278
[TBL] [Abstract][Full Text] [Related]
13. Recombinant production, crystallization and crystal structure determination of dihydroorotate dehydrogenase from Leishmania (Viannia) braziliensis.
Reis RA; Lorenzato E; Silva VC; Nonato MC
Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):547-52. PubMed ID: 25945707
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.
Trapani S; Linss J; Goldenberg S; Fischer H; Craievich AF; Oliva G
J Mol Biol; 2001 Nov; 313(5):1059-72. PubMed ID: 11700062
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling of T. cruzi and L. major NADH-dependent fumarate reductases: ligand docking, molecular dynamics validation, and insights on their binding modes.
Merlino A; Vieites M; Gambino D; Coitiño EL
J Mol Graph Model; 2014 Mar; 48():47-59. PubMed ID: 24370672
[TBL] [Abstract][Full Text] [Related]
16. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase.
Pinheiro MP; Emery Fda S; Nonato MC
Curr Pharm Des; 2013; 19(14):2615-27. PubMed ID: 23116399
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate.
Inaoka DK; Takashima E; Osanai A; Shimizu H; Nara T; Aoki T; Harada S; Kita K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Oct; 61(Pt 10):875-8. PubMed ID: 16511183
[TBL] [Abstract][Full Text] [Related]
18. Dual binding mode of a novel series of DHODH inhibitors.
Baumgartner R; Walloschek M; Kralik M; Gotschlich A; Tasler S; Mies J; Leban J
J Med Chem; 2006 Feb; 49(4):1239-47. PubMed ID: 16480261
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies.
Arakaki TL; Buckner FS; Gillespie JR; Malmquist NA; Phillips MA; Kalyuzhniy O; Luft JR; Detitta GT; Verlinde CL; Van Voorhis WC; Hol WG; Merritt EA
Mol Microbiol; 2008 Apr; 68(1):37-50. PubMed ID: 18312275
[TBL] [Abstract][Full Text] [Related]
20. Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.
D'Antonio EL; Deinema MS; Kearns SP; Frey TA; Tanghe S; Perry K; Roy TA; Gracz HS; Rodriguez A; D'Antonio J
Mol Biochem Parasitol; 2015 Dec; 204(2):64-76. PubMed ID: 26778112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
